Childhood Screening Recommendations for Lead, Iron Deficiency, and Vitamin D Deficiency
Screen all children for iron deficiency anemia at 9-12 months of age, again at 15-18 months, and annually from ages 2-5 years if at high risk; screen for lead exposure based on local/state guidelines and risk factors, with universal screening recommended for high-risk populations (Medicaid-enrolled children, low-income families) at 9-12 months and again at 24 months; vitamin D screening is not routinely recommended for asymptomatic children but should be risk-based.
Iron Deficiency Screening
The CDC provides clear, risk-stratified guidance for iron deficiency anemia screening 1:
Universal Screening (High-Risk Populations)
- Initial screening: 9-12 months of age
- Follow-up: 6 months later (15-18 months)
- Ongoing: Annually from ages 2-5 years
High-risk populations include:
- Children from low-income families
- WIC-eligible children
- Migrant children
- Recently arrived refugee children
Selective Screening (Lower-Risk Populations)
Screen only children with specific risk factors at 9-12 months and 15-18 months:
- Preterm or low-birthweight infants
- Infants fed non-iron-fortified formula for >2 months
- Early introduction of cow's milk (before 12 months)
- Breastfed infants without adequate iron supplementation after 6 months
- Children consuming >24 oz daily of cow's milk
- Children with special health-care needs (chronic infections, inflammatory disorders, restricted diets)
The AAP 2016 update reinforces universal screening at 12 months with risk assessment at 15 and 30 months 2. This approach balances the significant neurodevelopmental consequences of iron deficiency against screening burden.
Critical pitfall: The USPSTF issued an "I" (insufficient evidence) statement in 2015 3, but this reflects research gaps rather than clinical guidance—defer to CDC/AAP recommendations in practice, as iron deficiency anemia causes irreversible developmental delays that persist even after treatment 4.
Lead Screening
Lead screening recommendations are state-dependent, reflecting geographic variation in housing age and exposure risk 5:
Universal Screening Populations
All children enrolled in Medicaid must be screened at:
- 12 months of age
- 24 months of age
This federal requirement exists because Medicaid-enrolled children have 3 times higher prevalence of elevated blood lead levels (9% vs 3%) and account for 60% of children with elevated levels 6.
Risk-Based Screening (Non-Medicaid)
Screen at 9-12 months and 24 months if:
- Living in housing built before 1960 (especially pre-1940)
- Living in deteriorating housing or recent renovation
- Sibling or playmate with elevated blood lead level
- Parent/household member with occupational lead exposure
- Living near industrial sites or heavy traffic
- Use of imported pottery, cosmetics, folk remedies, or spices
Follow local and state screening mandates—many jurisdictions require universal screening regardless of risk factors 5. Contact your state health department for specific requirements.
Screening Before 12 Months
For children initially screened before 12 months of age, consider retesting in 3-6 months for high-risk children, as lead exposure increases with mobility 5.
Key management point: Blood lead levels ≥5 μg/dL require environmental investigation, nutritional counseling (calcium and iron), and iron deficiency screening, as iron deficiency increases lead absorption 5. The association between elevated lead levels and iron deficiency is well-established 7, 8.
Vitamin D Screening
Routine universal vitamin D screening is not recommended for asymptomatic children based on available guideline evidence. The provided guidelines do not include specific vitamin D screening recommendations.
Risk-Based Approach
Consider screening in children with:
- Dark skin pigmentation (African-American, Hispanic populations have higher deficiency rates 9)
- Limited sun exposure
- Exclusive breastfeeding without supplementation
- Malabsorption disorders
- Chronic kidney disease
- Medications affecting vitamin D metabolism
Clinical context: While vitamin D deficiency is prevalent (71.6% in one study of anemic patients 10), and may interact with lead absorption 9, no major pediatric guidelines recommend universal screening in healthy children. Focus instead on universal supplementation (400 IU daily for all infants and children) rather than screening.
Practical Implementation Algorithm
At 9-12 months:
- Screen ALL children for iron deficiency (hemoglobin/hematocrit)
- Screen for lead if: Medicaid-enrolled, high-risk factors present, or per state mandate
- Assess vitamin D supplementation compliance (do not routinely screen)
At 15-18 months:
- Risk assessment for iron deficiency; screen if risk factors identified
- No routine lead screening unless initial screening was abnormal or new risk factors
At 24 months:
- Screen for lead if: Medicaid-enrolled or per state requirements
- Risk assessment for iron deficiency; screen if risk factors present
Ages 2-5 years:
- Annual iron deficiency screening for high-risk populations
- Annual risk assessment for all others
- Lead screening per state requirements (typically not routine after age 2 unless new exposure)
Common pitfall: Do not wait for symptoms to screen—both iron deficiency and lead toxicity cause irreversible neurodevelopmental damage before clinical symptoms appear 5, 4. The window for prevention is narrow, making timely screening essential for protecting long-term cognitive outcomes.